Zekavat et al.33 identified that the presence of CHIP mediated by mutations in the DNA damage response gene, TP53, was associated with a 1.7-fold increase in incident peripheral arterial disease (PAD). This evidence concerns the gene TP53 and peripheral arterial disease.